The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2017
Filed:
Mar. 22, 2017
Applicants:
Im Therapeutics, Inc., Broomfield, CO (US);
The Regents of the University of Colorado, a Body Corporate, Denver, CO (US);
Inventors:
Steve Orndorff, Broomfield, CO (US);
Aaron Michels, Centennial, CO (US);
Peter Gottlieb, Englewood, CO (US);
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE, Denver, CO (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); G01N 33/564 (2006.01); A61K 38/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 9/0053 (2013.01); A61K 38/28 (2013.01); A61K 45/06 (2013.01); G01N 33/564 (2013.01); G01N 2800/042 (2013.01);
Abstract
Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-α-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-α-methyldopa.